Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases.
Alessandro GiolloEugenia BertoldoGiovanni AdamiAdam J CybulskiAngelo FassioGiovanni OrsoliniLuca IdolazziDavide GattiOmbretta ViapianaMaurizio RossiniPublished in: Annals of the rheumatic diseases (2020)
Keyphrases
- coronavirus disease
- rheumatoid arthritis
- disease activity
- sars cov
- systemic lupus erythematosus
- juvenile idiopathic arthritis
- rheumatoid arthritis patients
- ankylosing spondylitis
- emergency department
- primary care
- respiratory syndrome coronavirus
- electronic health record
- stem cells
- mesenchymal stem cells
- artificial intelligence